NCT00511069View on ClinicalTrials.gov

Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions
Leukemia
Interventions
DRUG

Bortezomib

Trial Locations (1)

40138

"Policlinico S.Orsola-Malpighi-Istituto di Ematologia L e A Seragnoli", Bologna

All Listed Sponsors
lead

University of Bologna

OTHER

NCT00511069 - Velcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ Leukemia | Biotech Hunter | Biotech Hunter